2020
DOI: 10.1089/neu.2019.6537
|View full text |Cite
|
Sign up to set email alerts
|

Penetrating Traumatic Brain Injury Triggers Dysregulation of Cathepsin B Protein Levels Independent of Cysteine Protease Activity in Brain and Cerebral Spinal Fluid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
20
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 19 publications
(21 citation statements)
references
References 59 publications
0
20
1
Order By: Relevance
“…Portions of the dissected right lateral neocortices of 6 h–4w sham and injured animals were homogenized in 50 μM citric acid at a pH 6.0, spun at 12,000 xg at 4° C for 10 min and the supernatant of the whole homogenate was collected. Protein concentrations were measured using a NanoDrop Lite (Thermo Fisher Scientific, Wilmington, DE) and Cathepsin B activity was measured in a 96-well plate, each well containing 2x Assay Buffer (100 mM sodium acetate pH 5.5, 2 mM EDTA, 200 mM sodium chloride, 8 mM DTT), 2 μg of neocortex whole homogenate, and Z-Phe-Arg-7-amino-4-(trifluoromethyl) coumarin (ZFR-AMC), a substrate for cysteine proteases that fluoresces upon cleavage by Cathepsin B ( Hook et al, 2013 ; Boutté et al, 2020 ; Yoon et al, 2021 ). Assay specificity for Cathepsin B was validated using Cathepsin B specific inhibitor, CA-074, and general cystine protease inhibitor, E64c, pre-incubated in brain homogenate ( Supplementary Figure 2 ).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Portions of the dissected right lateral neocortices of 6 h–4w sham and injured animals were homogenized in 50 μM citric acid at a pH 6.0, spun at 12,000 xg at 4° C for 10 min and the supernatant of the whole homogenate was collected. Protein concentrations were measured using a NanoDrop Lite (Thermo Fisher Scientific, Wilmington, DE) and Cathepsin B activity was measured in a 96-well plate, each well containing 2x Assay Buffer (100 mM sodium acetate pH 5.5, 2 mM EDTA, 200 mM sodium chloride, 8 mM DTT), 2 μg of neocortex whole homogenate, and Z-Phe-Arg-7-amino-4-(trifluoromethyl) coumarin (ZFR-AMC), a substrate for cysteine proteases that fluoresces upon cleavage by Cathepsin B ( Hook et al, 2013 ; Boutté et al, 2020 ; Yoon et al, 2021 ). Assay specificity for Cathepsin B was validated using Cathepsin B specific inhibitor, CA-074, and general cystine protease inhibitor, E64c, pre-incubated in brain homogenate ( Supplementary Figure 2 ).…”
Section: Methodsmentioning
confidence: 99%
“…While Cath B usually functions within the acidic environment of the lysosome, it also has endopeptidase activity at the more neutral pH of the cytosol, unlike other lysosomal proteases. Within the context of TBI, Cath B has been found to be upregulated in rodent TBI models of focal lesions, such as the controlled cortical impact (CCI) and penetrating ballistic-like brain injury (PBBI) ( Luo et al, 2010 ; Hook et al, 2013 ; Boutté et al, 2020 ). Additional findings within patient cerebrospinal fluid also indicated an upregulation of Cath B within hours or days post-penetrating TBI compared to non-TBI controls, providing further evidence that Cath B could play a role in TBI pathology ( Boutté et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…This model has been extensively characterized; several studies have found that key features are generally highest at 1, 3, or 7 days post-injury. For instance, blood brain barrier disruption is greatest within 1 day ( Cunningham et al, 2014 ), while indices of inflammation, cell loss, and protein fragmentation are prominent at 3–7 days post-injury ( Boutte et al, 2016 , 2020 ; Cartagena et al, 2016 ; DeDominicis et al, 2018 ). Collectively, these features are involved in severe TBI progression for which miRNA may be involved.…”
Section: Introductionmentioning
confidence: 99%
“…The ability to predict mortality and injury severity may facilitate the development of clinical guidelines for managing pTBI. 15 Several biomarkers are reported to be altered after PBBI, including GFAP (glial fibrillary acidic protein; astrogliosis/astroglial injury), [16][17][18] brain-derived neurotrophic factor (BDNF; neurogenesis/neuroprotection), 19 ubiquitin C-terminal hydrolase-L1 (UCH-L1; neuronal cell body injury), 20 cathepsin B (CatB; apoptosis/ cell necrosis), 21 and microRNA (miRNA; astrogliosis/ inflammation/neurodegeneration). 22,23 Considering that pTBI and polytrauma often occur concurrently in the setting of emergency medicine, we hypothesized that the use of brain-specific and global injury biomarkers can reliably identify HX+HS and frontal PBBI with and without systemic insults (HX+HS) to diagnose and differentiate combined injury from isolated pTBI.…”
Section: Introductionmentioning
confidence: 99%
“…Several biomarkers are reported to be altered after PBBI, including GFAP (glial fibrillary acidic protein; astrogliosis/astroglial injury), 16–18 brain-derived neurotrophic factor (BDNF; neurogenesis/neuroprotection), 19 ubiquitin C-terminal hydrolase-L1 (UCH-L1; neuronal cell body injury), 20 cathepsin B (CatB; apoptosis/cell necrosis), 21 and microRNA (miRNA; astrogliosis/inflammation/neurodegeneration). 22 , 23 …”
Section: Introductionmentioning
confidence: 99%